Kyste hydatique du masséter: a propos d’un cas

La localisation cervico faciale et particulièrement musculaire massétérine est exceptionnelle même en zone d’endémie. Le kyste hydatique au niveau de cette localisation pose un problème de diagnostic et des difficultés thérapeutiques du fait de la présence de filets nerveux du VII. Les auteurs rapportent un cas rare de localisation primaire d’un kyste hydatique au niveau du muscle masséter.Mots clès : Kyste hydatique, face, masséter, imagerie, chirurgie

Mucormycose rhinosinusienne a extension palatine

Les mucormycoses sont des infections fongiques, aigues, rares et souvent fatales. Elles touchent avec prédilection les sujets  immunodéprimés. La forme rhinocérébrale est la plus fréquente. Le diagnostic repose sur l’examen clinique, anatomopathologique et mycologique. L’approche thérapeutique doit être multidisciplinaire. Les auteurs rapportent l’histoire clinique d’un patient, ayant présenté une mucormycose rhinosinusienne avec atteinte du palais au décours d’une infection dentaire. A travers cette observation, ils discutent les différents aspects cliniques, les moyens du diagnostic et les modalités thérapeutiques de la mucormycose rhinocérébrale.Mots clés : Infection fongique, mucormycose rhinocérébrale, zygomycètes, pronostic, traitement

Schwannome du nerf facial intraparotidien: a propos d\'un cas

No Abstract. Journal Tunisien d\'ORL et de chirurgie cervico-faciale Vol. 17 2006: pp. 51-5

Cardiac rehabilitation in the elderly patient in eight rehabilitation units in Western Europe: Baseline data from the EU-CaRE multicentre observational study.

BACKGROUND Due to the progressive deconditioning, comorbidities and higher complication rates, elderly patients are in particular need of cardiac rehabilitation. We compared elderly patients (65+ years old) participating in cardiac rehabilitation, focusing on baseline characteristics, risk factor control and functional assessment. METHODS The EU-CaRE study is a prospective study comparing cardiac rehabilitation in eight centres across Western Europe. Consecutive patients with acute coronary syndrome, stable coronary artery disease and heart valve replacement undergoing cardiac rehabilitation were included. RESULTS Of 1633 patients (median age 72 years) participating, 54% had acute coronary syndrome, 33% had stable coronary artery disease and 13% followed valve replacement. Fifty-five per cent had undergone percutaneous coronary intervention and 29% coronary artery bypass grafting. Characteristics varied across centres: 23% (17-27%) were women, 4% (0-12%) were of non-European origin and 16% (4-32%) were living alone. Median time from index event to start of cardiac rehabilitation varied from 11 to 49 days (p < 0.001). Mean VO2peak was relatively low (16 mL/kg per min) and varied significantly between the participating centres, largely unaffected by multivariable adjustment. Overall patients received guideline recommended treatment: 93% (87-97%) were on a statin and 70% (55-85%) an angiotensin-converting enzyme inhibitor/angiotensin receptor blocker. However, risk factor control was inadequate: 58% had three or more risk factors not controlled. CONCLUSION EU-CaRE provides a snapshot of the elderly population with heart disease participating in cardiac rehabilitation across countries in Western Europe. Risk factors and exercise capacity indicate the continued need for cardiac rehabilitation in these patients. Of concern, the lag-time to start of cardiac rehabilitation needs improvement in many centres

Cardiac rehabilitation of elderly Patients in eight rehabilitation units in Western Europe: Outcome data from the EU-CaRE multi-centre observational Study

AIMS The European Cardiac Rehabilitation in the Elderly (EU-CaRE) HORIZON 2020 project compares the sustainable effects of cardiac rehabilitation (CR) in elderly patients. METHODS AND RESULTS A total of 1633 patients with coronary artery disease (CAD) or heart valve replacement (HVR), with or without revascularization, aged 65 or above, who participated in CR were included. Peak oxygen uptake (VO2peak), smoking, body mass index, diet, physical activity, serum lipids, psychological distress and medication were assessed before and after CR (T0 and T1) and after 12 months (T2). Patients undergoing coronary artery bypass surgery or surgical HVR had lower VO2peak at T0 and a greater increase to T1 and T2 (2.8 and 4.4 ml/kg/min, respectively) than CAD patients undergoing percutaneous or no revascularization (1.6 and 1.4 ml/kg/min, respectively). After multivariable adjustment, earlier CR uptake was associated with greater improvements in VO2peak. The proportion of CAD patients with three or more uncontrolled risk factors declined from 58.4% at T0 to 40.1% at T2 (p < 0.0001). Psychological distress scores all improved and adherence to medication was overall good at all sites. There were significant differences in risk factor burden across sites, but no CR program was superior to others. CONCLUSIONS The outcomes of VO2peak in CR programs across Europe seemed mainly determined by timing of uptake and were maintained or even further improved at 1-year follow-up. Despite significant improvements, 40.1% of CAD patients still had three or more risk factors not at target after 1 year. Differences across sites could not be ascribed to characteristics of the CR programs offered